Evolus, Inc. Common Stock revenue for the last year amounted to 266.27 M USD, the most of which — 264.31 M USD — came from its highest performing source at the moment, Cash-pay Aesthetic Product, the year earlier bringing 199.72 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Evolus, Inc. Common Stock 253.16 M USD.